Upregulation of connective tissue growth factor in a rat model of chronic allograft nephropathy

Nephrology

Volumn 12, Issue 2, 2007, Pages 166-171

  Tu, Zhidan ^a   Shi, Yujun ^a   Wang, Jinjing ^a   Bao, Ji ^a   Bu, Hong ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Chronic allograft nephropathy; Connective tissue growth factor; Renal transplantation

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; COLLAGEN; CONNECTIVE TISSUE GROWTH FACTOR; CREATININE; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHRONIC ALLOGRAFT NEPHROPATHY; CONTROL GROUP; CONTROLLED STUDY; CORRELATION COEFFICIENT; CREATININE BLOOD LEVEL; DISEASE SEVERITY; EPITHELIUM CELL; FIBROSING ALVEOLITIS; GLOMERULOSCLEROSIS; IMMUNOHISTOCHEMISTRY; KIDNEY FIBROSIS; KIDNEY GRAFT; KIDNEY TRANSPLANTATION; LEWIS RAT; MALE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RAT STRAIN; STAINING; TIME; UPREGULATION; WESTERN BLOTTING;

ACTINS; ANIMALS; CHRONIC DISEASE; COLLAGEN; DISEASE MODELS, ANIMAL; FIBROSIS; GRAFT REJECTION; IMMEDIATE-EARLY PROTEINS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; KIDNEY; KIDNEY DISEASES; KIDNEY TRANSPLANTATION; MALE; NEPHRECTOMY; RATS; RATS, INBRED F344; RATS, INBRED LEW; TIME FACTORS; TRANSFORMING GROWTH FACTOR BETA; TRANSPLANTATION, HOMOLOGOUS; UP-REGULATION;

EID: 33947241300     PISSN: 13205358     EISSN: 14401797     Source Type: Journal    
DOI: 10.1111/j.1440-1797.2007.00772.x     Document Type: Article

References (27)

1. Meyers CM, Kirk AD. Workshop on late renal allograft dysfunction. Am. J. Transplant. 2005; 5: 1600-605.
2. Nangaku M. Mechanisms of tubulointerstitial injury in the kidney: Final common pathways to end-stage renal failure. Intern. Med. 2004; 43: 9-17.
3. Cornell LD, Colvin RB. Chronic allograft nephropathy. Curr. Opin. Nephrol. Hypertens. 2005; 14: 229-34.
4. Schwarz A, Mengel M, Gwinner W et al. Risk factors for chronic allograft nephropathy after renal transplantation: A protocol biopsy study. Kidney Int. 2005; 67: 341-8.
5. Joosten SA, Sijpkens YW, van Kooten C, Paul LC. Chronic renal allograft rejection: Pathophysiologic considerations. Kidney Int. 2005; 68: 1-13.
6. Branton MH, Kopp JB. TGF-beta and fibrosis. Microbes Infect. 1999; 1: 1349-65.
7. Mauviel A. Transforming growth factor-beta: A key mediator of fibrosis. Methods Mol. Med. 2005; 117: 69-80.
8. Leask A, Holmes A, Abraham DJ. Connective tissue growth factor: A new and important player in the pathogenesis of fibrosis. Curr. Rheumatol. Rep. 2002; 4: 136-42.
9. Takigawa M. CTGF/Hcs24 as a multifunctional growth factor for fibroblasts, chondrocytes and vascular endothelial cells. Drug News Perspect. 2003; 16: 11-21.
10. Abdel Wahab N, Mason RM. Connective tissue growth factor and renal diseases: Some answers, more questions. Curr. Opin. Nephrol. Hypertens. 2004; 13: 53-8.
11. Gupta S, Clarkson MR, Duggan J, Brady HR. Connective tissue growth factor: Potential role in glomerulosclerosis and tubulointerstitial fibrosis. Kidney Int. 2000; 58: 1389-99.
12. Nguyen TQ, Tarnow L, Andersen S et al. Urinary connective tissue growth factor excretion correlates with clinical markers of renal disease in a large population of type 1 diabetic patients with diabetic nephropathy. Diabetes Care 2006; 29: 83-8.
13. Kobayashi T, Inoue T, Okada H et al. Connective tissue growth factor mediates the profibrotic effects of transforming growth factor-beta produced by tubular epithelial cells in response to high glucose. Clin. Exp. Nephrol. 2005; 9: 114-21.
14. Nankivell BJ, Borrows RJ, Fung CL, O'Connell PJ, Chapman JR, Allen RD. Delta analysis of posttransplantation tubulointerstitial damage. Transplantation 2004; 78: 434-41.
15. Gabbiani G. The biology of the myofibroblast. Kidney Int. 1992; 41: 530-32.
16. Kamada N. A description of cuff techniques for renal transplantation in the rat. Transplantation 1985; 39: 93-5.
17. Racusen LC, Solez K, Colvin RB et al. The Banff 97 working classification of renal allograft pathology. Kidney Int. 1999; 55: 713-23.
18. Liu Y. Renal fibrosis: New insights into the pathogenesis and therapeutics. Kidney Int. 2006; 69: 213-17.
19. Ito Y, Aten J, Bende RJ et al. Expression of connective tissue growth factor in human renal fibrosis. Kidney Int. 1998; 53: 853-61.
20. Muller GA, Schettler V, Muller CA et al. Prevention of progression of renal fibrosis: How far are we? Kidney Int. 1996; 49 (Suppl. 54): S75-82.
21. Muchaneta KE. Myofibroblast phenotypes expression in experimental renal scarring. Nephrol. Dial. Transplant. 1997; 12: 904-15.
22. Zhang C, Meng X, Zhu Z, Liu J, Deng A. Connective tissue growth factor regulates the key events in tubular epithelial to myofibroblast transition in vitro. Cell Biol. Int. 2004; 28: 863-73.
23. Crean JK, Lappin D, Godson C, Brady HR. Connective tissue growth factor: An attractive therapeutic target in fibrotic renal disease. Expert Opin. Ther. Targets 2001; 5: 519-30.
24. Inoue T, Okada H, Kobayashi T et al. Hepatocyte growth factor counteracts transforming growth factor-beta1, through attenuation of connective tissue growth factor induction, and prevents renal fibrogenesis in 5/6 nephrectomized mice. FASEB J. 2003; 17: 268-70.
25. Yokoi H, Sugawara A, Mukoyama M et al. Role of connective tissue growth factor in profibrotic action of transforming growth factor-beta: A potential target for preventing renal fibrosis. Am. J. Kidney Dis. 2001; 38: S134-8.
26. Yokoi H, Mukoyama M, Nagae T et al. Reduction in connective tissue growth factor by antisense treatment ameliorates renal tubulointerstitial fibrosis. J. Am. Soc. Nephrol. 2004; 15: 1430-40.
27. Zhang C, Meng X, Zhu Z et al. Connective tissue growth factor regulates the key events in tubular epithelial to myofibroblast transition in vitro. Cell Biol. Int. 2004; 28: 863-73.